Vaccines Adapted for Variants Will Not Need Lengthy Testing, F.D.A. Says
The new guidance will speed the development of vaccines that protect against more contagious Coronavirus variants. Vaccine developers will not have to conduct lengthy randomized controlled trials for vaccines adapted to protect against concerning Coronavirus variants, according to the Food and Drug Administration. In a time when scientists are increasingly concerned about how variants could … Read more